News - Idera Pharmaceuticals

Filter

Current filters:

Idera Pharmaceuticals

Popular Filters

Merck KGaA returns rights to IMO-2055 in oncology to Idera Pharma

01-12-2011

USA-based Idera Pharmaceuticals (Nasdaq: IDRA) revealed yesterday that it has regained global rights…

Idera PharmaceuticalsLicensingMerck KGaAOncologyPharmaceuticalResearch

Back to top